VG Life Sciences Inc. (VGLS)

Market Cap	2.11M
Revenue (ttm)	n/a
Net Income (ttm)	-4.30M
Shares Out	21.10B
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,200,351
Average Volume	581,920
Open	0.0001
Previous Close	0.0001
Day's Range	n/a
52-Week Range	n/a
Beta	57.57
RSI	52.02
Earnings Date	n/a

About VG Life Sciences

VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide (CLIP) that is displayed on specific B cells that leads to chronic inflammation. The company also provides metabolic disruption technology (MDT) compounds impede tumo...

• Industry: Real Estate - Development
• Sector: Real Estate
• Founded: 1995
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: VGLS